Research
Hormonal
Aging is associated with profound changes in epigenetic patterns, including genomic hypomethylation and promoter-specific hypermethylation, which may contribute to age-related diseases like cancer and neurodegeneration.
Understand that aging involves natural epigenetic shifts. While you cannot stop aging, dietary choices can influence these epigenetic patterns, potentially supporting healthy aging and reducing disease risk.
GoodSupportsHIGH confidence
Aging and age-related diseases are associated with profound changes in epigenetic patterns... Total methylcytosine content is prone to decrease by aging, leading to genomic hypomethylation in most vertebrate tissues, whereas promoter regions tend to undergo paradoxical hypermethylation in many genes.
Why this rating
Supported by extensive literature cited in the review, including human and animal studies.
Source
Nutritional influences on epigenetics and age-related disease
Lara K Park et al. · Proceedings of The Nutrition Society · 2011
DOI 10.1017/s0029665111003302
narrative_reviewCited 232×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Nutrients involved in one-carbon metabolism (folate, B12, B6, choline, betaine) regulate DNA methylation by modulating the levels of the methyl donor S-adenosylmethionine (SAM) and the inhibitor S-adenosylhomocysteine (SAH).Moderate
- Bioactive food components such as genistein, EGCG, sulforaphane, and curcumin can modify DNA methylation and histone acetylation, potentially acting as chemopreventive agents by reactivating silenced tumor suppressor genes.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →